A Covid drug that has been designed to stop the risk of vulnerable patients needing hospital treatment is now available in NHS hospitals today.
The drug sotrovimab is an antibody-based drug that is being given to transplant recipients, cancer patients, and other high-risk groups.
It is designed to be given quickly after symptoms develop to help prevent people from falling seriously ill with the disease.
Tests have also shown that it should work against the Omicron variant.
The NHS delivered another record-breaking day for booster jabs yesterday — with a total of 830,403 people getting their vital protection.
— NHS England and NHS Improvement (@NHSEngland) December 19, 2021
If you're 18 or over and had your second dose over 2 months ago, visit https://t.co/ocH1SqGFXG to #GetBoostedNow. pic.twitter.com/Llyc9FrkHb
The national medical director of NHS England, Professor Steven Powis, has said that if you're at high risk you will be contacted and "if eligible, you will be able to get access to these new treatments."
Up until now, most Covid treatments have been for patients already in hospitals, but now new drugs are being designed to target vulnerable patients at early stages of infection to stop the need for hospital treatment.
Across the UK, around 1.3 million high-risk NHS patients will be eligible for the Sotrovimab drug.
The drug is most effective within the first five days after infection as it hopes to avoid the need for hospital treatment.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereLast Updated:
Report this comment Cancel